Experimental study reveals macrophage RSAD2 drives mitochondrial DNA synthesis and inflammatory signaling in injured mouse skin, highlighting a metabolic circuit governing tissue repair.
It is well established that mitochondrial DNA (mtDNA) synthesis governs macrophage function, yet its role in tissue repair and inflammation remains poorly understood. Using a mouse skin injury model combined with spatial transcriptomics and functional assays, we identify radical s-adenosyl methionine domain containing 2 (RSAD2) as a critical regulator of mtDNA-driven inflammation in macrophages. Mechanistically, RSAD2 directly binds the N-terminal domain of cytidylate monophosphate kinase 2 (CMPK2), a rate-limiting enzyme for mtDNA synthesis, and dually modulates its activity: it inhibits K63-linked ubiquitination to stabilize CMPK2, and recruits casein kinase 2 alpha 2 (Csnk2a2) to promote CMPK2 phosphorylation, thereby enhancing mtDNA production. Newly synthesized mtDNA amplifies inflammation through two coordinated pathways: activation of a cGAS-STING-IRF3-RSAD2 feedforward loop, and synergistic activation of the NLR family pyrin domain containing 3 (NLRP3) inflammasome. These pathways orchestrate inflammatory amplification in macrophages to modulate skin repair. Our work establishes macrophage RSAD2 as a central hub that coordinates two mtDNA-dependent inflammatory axes, revealing a feedforward immuno-metabolic circuit with broad implications for inflammation-driven diseases.
No takes yet. Share an insight, caveat, or question.
Yuan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: